Matches in SemOpenAlex for { <https://semopenalex.org/work/W40400977> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W40400977 endingPage "257" @default.
- W40400977 startingPage "251" @default.
- W40400977 abstract "The glycaemic and lipid effects of treatment with pioglitazone in combination with a stable insulin regimen were evaluated in patients with type 2 diabetes. Patients (n=566) receiving stable insulin regimens for > or = 30 days yet who had HbA1c > or = 8.0% and C-peptide > 0.7 microg/l were randomised to receive once-daily 15 mg pioglitazone, 30 mg pioglitazone, or placebo in a 16-week multicentre, double-blind, placebo-controlled trial. Per study protocol, the insulin dose was to remain unchanged, but could be decreased in response to hypoglycaemia. At the end of double-blind treatment, patients receiving pioglitazone (15 mg or 30 mg) showed statistically significant mean decreases relative to baseline HbA1c (-1.0 and -1.3, respectively; p<0.0001) and fasting plasma glucose (FPG) (-34.5 mg/dl [-1.92 mmol/l] and -48.0 mg/dl [-2.67 mmol/l], respectively; p<0.0001); these differences compared with placebo were also significant (p<0.0001). Pioglitazone (15 or 30 mg) yielded significant increases in HDL-C levels (mean increases ranging from +7.1% to + 9.3%) compared with baseline or placebo (p<0.01). The 30 mg dose also significantly reduced mean triglyceride levels (-23.7%) compared with placebo (p=0.0218). No consistent changes in TC or LDL-C levels were observed. The incidence of adverse events was similar in all treatment groups, although the incidences of weight increase, hypoglycaemia and oedema were higher among patients receiving insulin plus pioglitazone. There was no evidence of hepatotoxicity or drug-induced elevations of serum ALT > or = 3 x ULN. Pioglitazone, when added to stable insulin regimens, significantly improved HbA1c and FPG in type 2 diabetes. Pioglitazone treatment also provided significant benefit with respect to plasma HDL-C and triglyceride levels. Whether these lipid changes have an impact on overall diabetic complications remains to be determined." @default.
- W40400977 created "2016-06-24" @default.
- W40400977 creator A5008159694 @default.
- W40400977 creator A5045489578 @default.
- W40400977 creator A5070041052 @default.
- W40400977 creator A5082454717 @default.
- W40400977 creator A5084440394 @default.
- W40400977 date "2002-05-01" @default.
- W40400977 modified "2023-10-02" @default.
- W40400977 title "EFFICACY AND SAFETY OF PIOGLITAZONE IN TYPE 2 DIABETES: A RANDOMISED, PLACEBO‐CONTROLLED STUDY IN PATIENTS RECEIVING STABLE INSULIN THERAPY" @default.
- W40400977 cites W1984081543 @default.
- W40400977 cites W2012757283 @default.
- W40400977 cites W2015279471 @default.
- W40400977 cites W2023447984 @default.
- W40400977 cites W2028038659 @default.
- W40400977 cites W2037447341 @default.
- W40400977 cites W2054981406 @default.
- W40400977 cites W2068495554 @default.
- W40400977 cites W2114102308 @default.
- W40400977 cites W2116404316 @default.
- W40400977 cites W2140603676 @default.
- W40400977 cites W2165832533 @default.
- W40400977 cites W2769264260 @default.
- W40400977 cites W3023211482 @default.
- W40400977 cites W4248066341 @default.
- W40400977 doi "https://doi.org/10.1111/j.1742-1241.2002.tb11251.x" @default.
- W40400977 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12074206" @default.
- W40400977 hasPublicationYear "2002" @default.
- W40400977 type Work @default.
- W40400977 sameAs 40400977 @default.
- W40400977 citedByCount "112" @default.
- W40400977 countsByYear W404009772012 @default.
- W40400977 countsByYear W404009772013 @default.
- W40400977 countsByYear W404009772015 @default.
- W40400977 countsByYear W404009772016 @default.
- W40400977 countsByYear W404009772017 @default.
- W40400977 countsByYear W404009772018 @default.
- W40400977 countsByYear W404009772019 @default.
- W40400977 countsByYear W404009772022 @default.
- W40400977 crossrefType "journal-article" @default.
- W40400977 hasAuthorship W40400977A5008159694 @default.
- W40400977 hasAuthorship W40400977A5045489578 @default.
- W40400977 hasAuthorship W40400977A5070041052 @default.
- W40400977 hasAuthorship W40400977A5082454717 @default.
- W40400977 hasAuthorship W40400977A5084440394 @default.
- W40400977 hasConcept C126322002 @default.
- W40400977 hasConcept C134018914 @default.
- W40400977 hasConcept C142724271 @default.
- W40400977 hasConcept C197934379 @default.
- W40400977 hasConcept C204787440 @default.
- W40400977 hasConcept C27081682 @default.
- W40400977 hasConcept C2777180221 @default.
- W40400977 hasConcept C2778384471 @default.
- W40400977 hasConcept C2779306644 @default.
- W40400977 hasConcept C2781413609 @default.
- W40400977 hasConcept C555293320 @default.
- W40400977 hasConcept C71924100 @default.
- W40400977 hasConcept C90924648 @default.
- W40400977 hasConceptScore W40400977C126322002 @default.
- W40400977 hasConceptScore W40400977C134018914 @default.
- W40400977 hasConceptScore W40400977C142724271 @default.
- W40400977 hasConceptScore W40400977C197934379 @default.
- W40400977 hasConceptScore W40400977C204787440 @default.
- W40400977 hasConceptScore W40400977C27081682 @default.
- W40400977 hasConceptScore W40400977C2777180221 @default.
- W40400977 hasConceptScore W40400977C2778384471 @default.
- W40400977 hasConceptScore W40400977C2779306644 @default.
- W40400977 hasConceptScore W40400977C2781413609 @default.
- W40400977 hasConceptScore W40400977C555293320 @default.
- W40400977 hasConceptScore W40400977C71924100 @default.
- W40400977 hasConceptScore W40400977C90924648 @default.
- W40400977 hasIssue "4" @default.
- W40400977 hasLocation W404009771 @default.
- W40400977 hasLocation W404009772 @default.
- W40400977 hasOpenAccess W40400977 @default.
- W40400977 hasPrimaryLocation W404009771 @default.
- W40400977 hasRelatedWork W1983641721 @default.
- W40400977 hasRelatedWork W1994230976 @default.
- W40400977 hasRelatedWork W2026226896 @default.
- W40400977 hasRelatedWork W2033522292 @default.
- W40400977 hasRelatedWork W2042938358 @default.
- W40400977 hasRelatedWork W2066345847 @default.
- W40400977 hasRelatedWork W2082530614 @default.
- W40400977 hasRelatedWork W2121496639 @default.
- W40400977 hasRelatedWork W4240196000 @default.
- W40400977 hasRelatedWork W8919293 @default.
- W40400977 hasVolume "56" @default.
- W40400977 isParatext "false" @default.
- W40400977 isRetracted "false" @default.
- W40400977 magId "40400977" @default.
- W40400977 workType "article" @default.